CLINICAL_TRIALS
trial_result
· 2014-12-23
Clinical Trial Update: Sunitinib in Metastatic Renal Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating sunitinib for metastatic renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Istituto Clinico Humanitas | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED